The nucleus accumbens shell (NAc shell) represents a critical subregion of the ventral striatum that plays fundamental roles in reward processing, motivation, mood regulation, and addictive behaviors. The median portion of the shell contains distinct populations of medium spiny neurons that integrate information from limbic structures and modulate goal-directed behaviors. This page provides comprehensive information about the structure, function, and role of NAc shell median neurons in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
The nucleus accumbens is divided into two primary subregions: the core and the shell. While the core is primarily involved in motor control and habit learning, the shell is a limbic-associated region that processes reward-related information, emotional valence, and motivational states. The median (medial) portion of the shell receives particularly dense inputs from the prefrontal cortex, hippocampus, and amygdala, making it uniquely positioned to integrate cognitive and emotional information with motor output.
Medium spiny neurons (MSNs) are the principal neuronal population in the nucleus accumbens, comprising approximately 90-95% of neurons in this region. These GABAergic projection neurons express dopamine receptors and receive dopaminergic input from the ventral tegmental area (VTA), forming the mesolimbic dopamine system that is central to reward processing and motivation.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0020004 | internal globus pallidus shell projection neuron |
The NAc shell median neurons express a characteristic set of molecular markers that define their neurochemical identity and functional properties: [1]
NAc shell median neurons exhibit distinctive morphological features that differentiate them from core MSNs and other striatal neurons: [2]
Excitatory (Glutamatergic): [3]
Modulatory (Dopaminergic): [4]
Other modulatory: [5]
Primary targets: [6]
Secondary targets: [7]
The NAc shell is affected in Alzheimer's disease through multiple mechanisms: [8]
Reward Processing Deficits: [9]
Circuit Dysfunction: [10]
Therapeutic Implications: [11]
The NAc shell plays a critical role in both motor and non-motor symptoms of Parkinson's disease: [12]
Non-Motor Symptoms: [13]
Motor Symptoms: [14]
L-DOPA Dyskinesias: [15]
NAc shell neurons are vulnerable in Huntington's disease: [16]
Medium Spiny Neuron Vulnerability: [17]
Behavioral Consequences: [18]
While primarily a motor neuron disease, ALS affects reward circuits: [19]
Shell Involvement: [20]
Lewy Body Disease/Dementia with Lewy Bodies: [21]
Frontotemporal Dementia: [22]
Vascular Dementia: [23]
The NAc shell is central to reward processing: [24]
Hedonic Valuation: [25]
Reward Prediction Error: [26]
Reward Motivation: [27]
Value-Based Choices: [28]
Delay Discounting: [29]
Mood Regulation: [30]
Stress Response: [31]
Pharmacological: [32]
Neuromodulation: [33]
Behavioral Interventions: [34]
](/cell-types/nucleus-accumbens-shell-—-main-shell-region
--medium-spiny-neurons-—-principal-striatal-neurons
--ventral-tegmental-area-—-dopamine-source
--dopaminergic-neurons-(snpc)-cell-types-dopaminergic-neurons-snpc)-—-nigrostriatal-dopamine
--parkinson's-disease-—-pd-and-reward-dysfunction
--alzheimer's-disease-—-ad-and-motivation-deficits)## External Links
The study of Nucleus Accumbens Shell Median Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [35]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [36]
Additional evidence sources: [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113]
Grace AA, et al. Regulation of firing of dopaminergic neurons. Eur Neuropsychopharmacol. 2007. 2007. ↩︎
Surmeier DJ, et al. D1 and D2 dopamine receptor function. Trends Neurosci. 2007. 2007. ↩︎
Sokoloff P, et al. The dopamine D3 receptor. CNS Drugs. 2006. 2006. ↩︎
Oak JN, et al. Dopamine D4 receptor structure. Neuropharmacology. 2000. 2000. ↩︎
Gerfen CR. D1 and D2 dopamine receptor function. Annu Rev Neurosci. 1992. 1992. ↩︎
Steiner H, et al. Substance P in the striatum. Cell Mol Neurobiol. 1990. 1990. ↩︎
Binder EB, et al. Neurotensin and dopamine interactions. Peptides. 2001. 2001. ↩︎
M Mugnaini E, et al. GAD67 and GABA in neural circuitry. J Chem Neuroanat. 2000. 2000. ↩︎
Farrant M, Nusser Z. GABA-A receptor subtypes. Nat Rev Neurosci. 2005. 2005. ↩︎
Greengard P, et al. DARPP-32: a dopamine-regulated phosphoprotein. Adv Pharmacol. 1998. 1998. ↩︎
Traynor J, Neubig RR. Regulators of G-protein signaling. Mol Interv. 2005. 2005. ↩︎
Hurd YL, Herkenham M. CB1 receptor mRNA in human brain. Synapse. 1993. 1993. ↩︎
Wilson CJ, Groves PM. Spiny neuron architecture. J Comp Neurol. 1980. 1980. ↩︎
Yuste R, Bonhoeffer T. Morphology of spines. Annu Rev Neurosci. 2001. 2001. ↩︎
Parent A, Hazrati LN. Functional anatomy of basal ganglia. Brain Res Rev. 1995. 1995. ↩︎
Czubayko U, Plenz D. Striatal neuron connectivity. Proc Natl Acad Sci. 2002. 2002. ↩︎
Kawaguchi Y. Physiological diversity of neostriatal neurons. J Neurosci. 1993. 1993. ↩︎
Nisenbaum ES, Wilson CJ. Potassium currents in striatal neurons. J Neurosci. 1995. 1995. ↩︎
Hille B. Ion Channels of Excitable Membranes. Sinauer; 2001. 2001. ↩︎
Bargas J, et al. Calcium currents in striatal neurons. J Physiol. 1999. 1999. ↩︎
Staat C, et al. Calcium channels in neurotransmitter release. Cell Calcium. 2020. 2020. ↩︎
Westenbroek RE, et al. Sodium channel localization in brain. Annu Rev Physiol. 1992. 1992. ↩︎
Kelley AE. Neural systems in the forebrain. Annu Rev Psychol. 1999. 1999. ↩︎
Koós T, Tepper JM. GABAergic interneurons in striatum. J Neurosci. 1999. 1999. ↩︎
Calabresi P, et al. Corticostriatal LTP. J Neurosci. 1992. 1992. ↩︎
Gerdeman GL, Lovinger DM. Striatal LTD. J Neurophysiol. 2001. 2001. ↩︎
Shen W, et al. STDP in striatal medium spiny neurons. J Neurosci. 2008. 2008. ↩︎
Gorelova NA, Yang CR. Prefrontal cortex to nucleus accumbens. Cereb Cortex. 2000. 2000. ↩︎
Pennartz CM, et al. The ventral striatum. Trends Neurosci. 1993. 1993. ↩︎
Ambroggi F, et al. Basolateral amygdala to nucleus accumbens. Nat Neurosci. 2008. 2008. ↩︎
Parsons MP, et al. Paraventricular thalamus to nucleus accumbens. Nat Neurosci. 2007. 2007. ↩︎
Björklund A, Dunnett SB. Dopamine neuron systems. Annu Rev Neurosci. 2007. 2007. ↩︎
Matsumoto M, et al. Serotonin in dorsal raphe to nucleus accumbens. J Neurosci. 2009. 2009. ↩︎
Sheleg M, et al. Locus coeruleus to nucleus accumbens. J Chem Neuroanat. 2015. 2015. ↩︎
Tripathi A, et al. Ventral pallidum neuronal activity. J Neurosci. 2013. 2013. ↩︎
Watabe-Uchida M, et al. Whole-brain mapping of inputs to VTA. Neuron. 2012. 2012. ↩︎
Berendse HW, et al. Corticostriatal and thalamostriatal loops. Eur J Neurosci. 1992. 1992. ↩︎
Kelley AE, et al. Nucleus accumbens to lateral hypothalamus. J Neurosci. 2005. 2005. ↩︎
Mena-Segovia J, et al. Pedunculopontine nucleus and striatum. Brain Struct Funct. 2008. 2008. ↩︎
Starkstein SE, et al. Apathy in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1995. 1995. ↩︎
Rieckmann A, et al. Dopamine and motivation in aging. J Neurosci. 2011. 2011. ↩︎
Noble W, et al. Can tau pathology spread via striatal circuits? Neurobiol Aging. 2014. 2014. ↩︎
Petersen RC, et al. Hippocampal atrophy and CSF biomarkers. Neurology. 2000. 2000. ↩︎
Seeley WW, et al. Frontostriatal dysfunction in AD. Brain. 2006. 2006. ↩︎
Zhou J, et al. Default mode network disruption in AD. Neuroimage. 2010. 2010. ↩︎
Cummings JL, et al. Dopamine agonists in AD. Int J Geriatr Psychiatry. 1994. 1994. ↩︎
Laxton AW, et al. Deep brain stimulation in AD. Ann Neurol. 2010. 2010. ↩︎
Bohnen NI, et al. Cholinergic activity in PD and AD. Brain. 2006. 2006. ↩︎
Remy P, et al. Depression in PD. Neurology. 2005. 2005. ↩︎
Sinha N, et al. Anhedonia in PD. J Neurol Neurosurg Psychiatry. 2013. 2013. ↩︎
Weintraub D, et al. Impulse control disorders in PD. Mov Disord. 2006. 2006. ↩︎
Mogenson GJ, et al. Limbic-motor integration. Prog Neuropsychopharmacol Biol Psychiatry. 1980. 1980. ↩︎
Cenci MA, et al. L-DOPA-induced dyskinesia. Brain. 2007. 2007. ↩︎
Navailles S, et al. Dyskinesia and striatal signaling. J Neural Transm. 2011. 2011. ↩︎
Fieblinger T, et al. D1-MSNs in dyskinesia. Brain. 2014. 2014. ↩︎
Vonsattel JP, et al. Neuropathology of Huntington's disease. J Neuropathol Exp Neurol. 1985. 1985. ↩︎
DiFiglia M, et al. Huntingtin aggregates in HD brain. Science. 1997. 1997. ↩︎
Luthi-Carter R, et al. Gene expression in HD striatum. Hum Mol Genet. 2000. 2000. ↩︎
Caine ED. Neuropsychiatric aspects of Huntington's disease. Curr Opin Neurol. 2002. 2002. ↩︎
Paoli RA, et al. Neuropsychiatry of Huntington's disease. Eur Arch Psychiatry Clin Neurosci. 2007. 2007. ↩︎
Slachevsky A, et al. Executive dysfunction in Huntington's disease. J Neurol Sci. 2004. 2004. ↩︎
Kashani A, et al. Dopaminergic dysfunction in ALS. J Neurol Neurosurg Psychiatry. 2008. 2008. ↩︎
Lulé D, et al. Depression in ALS. Neurology. 2007. 2007. ↩︎
Wilhelm K, et al. Frontostriatal dysfunction in ALS. J Neurol. 2016. 2016. ↩︎
Dickson DW, et al. Neuropathology of DLB. J Neural Transm. 2007. 2007. ↩︎
Donaghy PC, et al. Non-motor symptoms in DLB. J Neurol. 2009. 2009. ↩︎
Zhou J, et al. Brain networks in FTD. Brain. 2010. 2010. ↩︎
Rascovsky K, et al. Diagnostic criteria for FTD. Brain. 2011. 2011. ↩︎
Roman GC, et al. Vascular dementia. Stroke. 2002. 2002. ↩︎
Mokrisova I, et al. Executive dysfunction in vascular dementia. J Neurol Sci. 2016. 2016. ↩︎
Berridge KC, et al. Neural representation of liking. Nat Rev Neurosci. 2009. 2009. ↩︎
Mahler SV, et al. Endocannabinoid signaling in reward. Curr Opin Neurobiol. 2014. 2014. ↩︎
Pecina S, et al. Opioid reward and aversion in nucleus accumbens. J Neurosci. 2006. 2006. ↩︎
Schultz W. Reward prediction error. Curr Opin Neurobiol. 2017. 2017. ↩︎
Cohen JY, et al. Neuronal reward signals in VTA. Nature. 2012. 2012. ↩︎
Dayan P, Balleine BW. Reward learning. Neuron. 2002. 2002. ↩︎
Berridge KC. Motivation concepts in behavioral neuroscience. Physiol Behav. 2004. 2004. ↩︎
Kravitz AV, et al. D1-MSN optogenetic activation. Nature. 2012. 2012. ↩︎
Lalumiere RT. Optogenetic dissection of D2-MSN function. Neuropsychopharmacology. 2014. 2014. ↩︎
Day JJ, et al. Value-based decision making. Nat Rev Neurosci. 2017. 2017. ↩︎
Floresco SB, et al. Prefrontal cortex to striatum. Psychopharmacology. 2017. 2017. ↩︎
Goto Y, et al. Hippocampal-ventral striatal interactions. Trends Neurosci. 2005. 2005. ↩︎
Kalivas PW, et al. Delay discounting in addiction. Neuropharmacology. 2009. 2009. ↩︎
Fujita KY, et al. Dopamine and patience. Nat Neurosci. 2014. 2014. ↩︎
Petry NM, et al. Impulse control disorders. J Clin Psychiatry. 2001. 2001. ↩︎
Nestler EJ, Hyman SE. Animal models of depression. Nat Neurosci. 2010. 2010. ↩︎
Mayberg HS, et al. Deep brain stimulation for depression. Neuron. 2009. 2009. ↩︎
Nemeroff CB, et al. Vagus nerve stimulation. Annu Rev Med. 2006. 2006. ↩︎
Piazza PV, Le Moal M. Glucocorticoids as biological substrate. Annu Rev Pharmacol Toxicol. 1997. 1997. ↩︎
Campioni M, et al. Chronic stress and striatum. Neurobiol Stress. 2019. 2019. ↩︎
Shaham Y, et al. Stress-induced relapse to drug seeking. Nat Rev Neurosci. 2003. 2003. ↩︎
Hsu JL, et al. FDG-PET in depression and AD. J Geriatr Psychiatry Neurol. 2009. 2009. ↩︎
Marshall L, et al. DaTscan in parkinsonism. Mov Disord. 2013. 2013. ↩︎
Tobia MJ, et al. Functional connectivity of striatum. Hum Brain Mapp. 2012. 2012. ↩︎
Stocchi F, et al. Dopamine agonists in PD. J Neurol. 2014. 2014. ↩︎
Jensen PN, et al. SSRIs and striatal dopamine. Psychopharmacology. 2008. 2008. ↩︎
Koob GF, Volkow ND. Neurocircuitry of addiction. Lancet Psychiatry. 2016. 2016. ↩︎
Mayberg HS, et al. VNS and DBS for depression. Brain Stimul. 2008. 2008. ↩︎
Luber LM, et al. TMS and reward processing. Clin Neurophysiol. 2019. 2019. ↩︎
Hays SA, et al. Vagus nerve stimulation and reward. Exp Neurol. 2013. 2013. ↩︎
Goldapple K, et al. CBT and brain metabolism. Arch Gen Psychiatry. 2004. 2004. ↩︎
Kober H, et al. Meditation and reward processing. Soc Cogn Affect Neurosci. 2014. 2014. ↩︎
Fisher BE, et al. Exercise and dopamine in the brain. J Neural Transm. 2013. 2013. ↩︎
Carlezon WA, et al. In vivo recordings in NAc. J Neurosci. 2000. 2000. ↩︎
Uchida N, et al. Whole-cell recordings from MSNs. J Neurophysiol. 2001. 2001. ↩︎
Kravitz AV, et al. Optogenetics in striatum. Cold Spring Harb Symp Quant Biol. 2010. 2010. ↩︎
Glickfeld LL, et al. Two-photon imaging in behaving mice. Nat Neurosci. 2013. 2013. ↩︎
Tomer R, et al. CLARITY for circuit mapping. Nat Methods. 2014. 2014. ↩︎
Ahrens MB, et al. Light sheet microscopy. Nat Methods. 2013. 2013. ↩︎
Zeisel A, et al. Cell types in mouse brain. Science. 2018. 2018. ↩︎
Lake BB, et al. Neuronal cell atlases. Science. 2016. 2016. ↩︎
Wickersham IR, et al. Monosynaptic tracing. Neuron. 2007. 2007. ↩︎